Gut Microbiota and Probiotics: Current Status and Their Role in Cancer Therapeutics.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 365, doi. 10.1002/ddr.21087
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2013 AND VI 74 AND IP 6
Results: 8
1
2
Therapeutic Potential of the Human Gastrointestinal Microbiome.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 385, doi. 10.1002/ddr.21093
- By:
- Publication type:
- Article
3
Salicylates and the Microbiota: A New Mechanistic Understanding of an Ancient Drug's Role in Dermatological and Gastrointestinal Disease.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 344, doi. 10.1002/ddr.21086
- By:
- Publication type:
- Article
4
Nutritional Targets for Modulation of the Microbiota in Obesity.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 393, doi. 10.1002/ddr.21092
- By:
- Publication type:
- Article
5
The Pharmacobiotic Potential of the Gastrointestinal Tract Micro-Biometabolome-Probiotic Connect: A Brief Commentary.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 353, doi. 10.1002/ddr.21091
- By:
- Publication type:
- Article
6
The Gut Microbiome: Insights for Personalized Medicine.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 341, doi. 10.1002/ddr.21095
- By:
- Publication type:
- Article
7
The Microbiome as a Therapeutic Target for Metabolic Diseases.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 376, doi. 10.1002/ddr.21088
- By:
- Publication type:
- Article
8
The Vaginal Microbiome: New Findings Bring New Opportunities.
- Published in:
- Drug Development Research, 2013, v. 74, n. 6, p. 360, doi. 10.1002/ddr.21090
- By:
- Publication type:
- Article